Nu Skin Enterprises Inc (NYSE:NUS) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Nu Skin Enterprises Inc develops and distributes consumer products including anti-aging skin products, body care, hair care, men’s care, oral care, sun protection and cosmetics under Nu Skin and Pharmanex brands. Nu Skin Enterprises Inc has a market cap of $3.52 billion; its shares were traded at around $63.45 with a P/E ratio of 22.71 and P/S ratio of 1.33. The dividend yield of Nu Skin Enterprises Inc stocks is 2.29%. Nu Skin Enterprises Inc had annual average EBITDA growth of 13.20% over the past ten years.
For the last quarter Nu Skin Enterprises Inc reported a revenue of $683.3 million, compared with the revenue of $666.2 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $2.7 billion, an increase of 17.5% from last year. For the last five years Nu Skin Enterprises Inc had an average revenue decline of 3.5% a year.
The reported diluted earnings per share was $2.16 for the year, a decline of 8.5% from the previous year. Over the last five years Nu Skin Enterprises Inc had an average EPS decline of 15.2% a year. The Nu Skin Enterprises Inc had a decent operating margin of 11.63%, compared with the operating margin of 12.04% a year before. The 10-year historical median operating margin of Nu Skin Enterprises Inc is 12.72%. The profitability rank of the company is 7 (out of 10).
At the current stock price of $63.45, Nu Skin Enterprises Inc is traded at close to its historical median P/S valuation band of $62.86. The P/S ratio of the stock is 1.33, while the historical median P/S ratio is 1.33. The stock lost 7.52% during the past 12 months.
For the complete 20-year historical financial data of NUS, click here.